Article
Clinical Utility and Impact of the Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay on Treatment Decision: A Single-Center Retrospective Study
2022-01-31
Abstract excerpt
<h4>Background: </h4> Metagenomic next-generation sequencing (mNGS) of microbial cell-free DNA (mcfDNA) allows for non-invasive pathogen detection from plasma. However, there is little data describing the optimal role for this assay in real-world clinical decision making. Methods We performed a single-center retrospective cohort study of adult patients for whom a mcfDNA test was sent between May 2019 and February...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4a00efbc-54ba-5855-8e7d-60f2dbcae1d6
- DOI
- 10.21203/rs.3.rs-1160543/v1
